Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9324303rdf:typepubmed:Citationlld:pubmed
pubmed-article:9324303lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0021027lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:9324303lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:9324303pubmed:issue10lld:pubmed
pubmed-article:9324303pubmed:dateCreated1997-10-23lld:pubmed
pubmed-article:9324303pubmed:abstractTextSeveral methods have been developed for the detection of minimal residual disease (MRD) in B cell tumors. Chromosomal translocations or the rearrangement of the immunoglobulin heavy chain (IgH) and T cell receptor genes are generally employed. We report a novel PCR method to detect MRD using IgH genes. IgH rearranged variable region (VDJ) were amplified from tumor specimens using consensus primers for variable and joining region genes. Complementarity-determining regions (CDR) were identified and used to generate tumor-specific primers. Two-round amplifications using primers derived from CDRs and joining or constant regions were performed for MRD detection. IgH nested-PCR approach was tested on a panel of 75 B cell tumors including acute lymphoblastic and chronic lymphocytic leukemias, non-Hodgkin's lymphomas and multiple myelomas. A VDJ sequence was obtained in 62 out of 75 cases (83%). Sensitivity using DNA or cDNA templates was 10(-5) and (-6), respectively. This method is specific and sensitive and provides a simple, non-radioactive approach for the evaluation of MRD in B cell tumors.lld:pubmed
pubmed-article:9324303pubmed:languageenglld:pubmed
pubmed-article:9324303pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9324303pubmed:citationSubsetIMlld:pubmed
pubmed-article:9324303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9324303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9324303pubmed:statusMEDLINElld:pubmed
pubmed-article:9324303pubmed:monthOctlld:pubmed
pubmed-article:9324303pubmed:issn0887-6924lld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:PileriAAlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:BoccadoroMMlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:CorradiniPPlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:AstolfiMMlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:GribbenJ GJGlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:LadettoMMlld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:VoenaCClld:pubmed
pubmed-article:9324303pubmed:authorpubmed-author:ProvanDDlld:pubmed
pubmed-article:9324303pubmed:issnTypePrintlld:pubmed
pubmed-article:9324303pubmed:volume11lld:pubmed
pubmed-article:9324303pubmed:ownerNLMlld:pubmed
pubmed-article:9324303pubmed:authorsCompleteYlld:pubmed
pubmed-article:9324303pubmed:pagination1793-8lld:pubmed
pubmed-article:9324303pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:meshHeadingpubmed-meshheading:9324303-...lld:pubmed
pubmed-article:9324303pubmed:year1997lld:pubmed
pubmed-article:9324303pubmed:articleTitleA novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors.lld:pubmed
pubmed-article:9324303pubmed:affiliationDipartimento di Medicina ed Oncologia Sperimentale, Azienda Ospedaliera San Giovanni Battista, Torino, Italy.lld:pubmed
pubmed-article:9324303pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:9324303pubmed:publicationTypeTechnical Reportlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9324303lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9324303lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9324303lld:pubmed